PAPPA Antikörper (AA 332-561)

Produktnummer ABIN5027424

Produktdetails anti-PAPPA Antikörper

Target: PAPPA (Pregnancy-Associated Plasma Protein A, Pappalysin 1 (PAPPA))

Bindungsspezifität: AA 332-561

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser PAPPA Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (IHC)

Aufreinigung: Protein G Chromatography

Immunogen: A partial length recombinant PAPP-A protein (amino acids 332-561) was used as the immunogen for this antibody.

Klon: ABM4C62

Isotyp: IgG2b kappa

Anwendungsinformationen

Applikationshinweise: IHC: 5-10 μg/mL

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 0.5 mg/mL

Buffer: PBS containing 0.05 % BSA, PH 7.4

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody at 4°C, stable for 6 months. For long-term storage, store at -20°C. Avoid repeated freeze and thaw cycles.

Details zu PAPPA

Target: PAPPA (Pregnancy-Associated Plasma Protein A, Pappalysin 1 (PAPPA))

Andere Bezeichnung: PAPP-A (PAPPA Produkte)

Synonyme: 8430414N03Rik antikoerper, IGFBP-4ase antikoerper, PAG1 antikoerper, PAPP-A antikoerper, ASBABP2 antikoerper, DIPLA1 antikoerper, PAPA antikoerper, PAPPA1 antikoerper, Pappa antikoerper, pappalysin 1 antikoerper, pregnancy-associated plasma protein A antikoerper, PAPPA antikoerper, Pappa antikoerper, Pappa1 antikoerper

Hintergrund: PAPP-A (pregnancy-associated plasma protein A) is a zinc metalloproteinase in the insulin-like growth factor system that is expressed by tissues outside of pregnancy and involved in normal and dysregulated growth. It has prognostic impact in pregnancy and acute coronary syndrome. PAPP-A regulate the activity of insulin-like growth factor (IGF) signal pathway through proteolytic degradation of IGF binding proteins (IGFBPs) thereby increasing the local concentration of free IGFs available to receptors. PAPP-A levels is associated with abnormal glucose metabolism and increased risk of atherosclerosis in AGHD (Adult Growth Hormone Deficiency) patients.

Gen-ID: 60676

UniProt: Q9BXP8